Table 7.
Bivariate regression between TB study covariates
| Pooled prevalence of TB infection |
||
|---|---|---|
| 95% CI | p-value | |
| Comparative Studies | ||
| Non ‘minority indigenous’ populations | 1.00 | |
| Minority indigenous populations | 1.00032 (0.85, 1.18) | 0.996 |
| WHO regions | ||
| SEAR | 1.00 | |
| WPR | 0.99 (0.95, 1.04) | 0.783 |
| WHO Mortality Strata | ||
| B | 1.00 | |
| D | 1.00 (0.95, 1.06) | 0.985 |
| Countries | ||
| India | 1.00 | |
| Malaysia | 1.00 (0.94, 1.07) | 0.895 |
| Year of data collection | ||
| 1945–1970 | 1.00 | |
| 1971–1995 | 0.98 (0.94, 1.03) | 0.380 |
| 1996–2020 | 1.00 (0.95, 1.06) | 0.863 |
|
Sex Female Male |
1.00 1.02 (0.99, 1.05) |
0.218 |
| Diagnostic methods | ||
| Clinical | 1.00 | |
| Culture | 1.01 (0.98, 1.04) | 0.581 |
| Smear | 1.02 (0.97, 1.07) | 0.468 |
| Screening Method | ||
| Chest symptoms | 1.00 | |
| No pre-screening | 1.06 (0.94, 1.19) | 0.354 |
Note: Bivariate meta-regression analysis was only undertaken where there were 3 or more data sets